LONDON (dpa-AFX) - Diageo plc (DGE.L) announced its financial support of the UK Thalidomide Trust will increase by 45 million pounds. Diageo has increased its financial support to the beneficiaries of the Thalidomide Trust through a one-off payment of 27 million pounds. Diageo said the net of tax charge to discontinued operations in the income statement in the six months ended 31 December 2016, including the additional elements of funding above and changes to the discount rate and inflation rate applied to the existing thalidomide provision, will be approximately 60 million pounds.
The aim of the Thalidomide Trust is to provide relief and assistance for those people born damaged as a result of their mothers having taken the drug Thalidomide during their pregnancy. Diageo said it is committed to the long term support of the Thalidomide Trust and its beneficiaries and the new agreement underlines the commitment.
Copyright RTT News/dpa-AFX